EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $515,000 | +442.1% | 32,870 | +682.1% | 0.02% | +500.0% |
| Q1 2022 | $95,000 | +31.9% | 4,203 | +6.6% | 0.00% | +50.0% |
| Q4 2021 | $72,000 | -82.0% | 3,941 | -77.8% | 0.00% | -85.7% |
| Q1 2021 | $401,000 | +105.6% | 17,757 | +123.1% | 0.01% | -33.3% |
| Q3 2020 | $195,000 | +242.1% | 7,959 | +140.6% | 0.02% | -16.0% |
| Q1 2020 | $57,000 | -61.2% | 3,308 | -60.2% | 0.02% | -40.5% |
| Q3 2019 | $147,000 | +182.7% | 8,302 | +244.3% | 0.04% | +200.0% |
| Q2 2019 | $52,000 | +57.6% | 2,411 | +75.0% | 0.01% | +7.7% |
| Q1 2019 | $33,000 | -10.8% | 1,378 | -16.4% | 0.01% | -31.6% |
| Q1 2018 | $37,000 | +146.7% | 1,648 | +227.6% | 0.02% | +72.7% |
| Q4 2017 | $15,000 | +66.7% | 503 | +43.3% | 0.01% | +83.3% |
| Q3 2017 | $9,000 | -75.7% | 351 | -79.2% | 0.01% | -87.5% |
| Q1 2017 | $37,000 | +208.3% | 1,687 | +116.3% | 0.05% | +300.0% |
| Q4 2016 | $12,000 | – | 780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |